Syngenta Group Ventures is an institutional investor (Corporate VCs) founded in 2000 and headquartered in Basel, Switzerland. Syngenta Ventures is an Early stage corporate venture capital firm investing in Europe and the US. The firm focuses its investments in Life-Sciences sectors which include BioTech R&D, Biopharma, Diagnostics. Portfolio companies include Biognosys, GreenLight Biosciences, Illumitex, Metabolon. Notable portfolio companies: Biognosys, GreenLight Biosciences, Illumitex, Metabolon.

Stage

seed, early-stage, Series A, Series B, Series C, growth, seed, early-stage, Series A, Series B, Series C, growth

Check size

$10M-$50M

HQ

Basel, Switzerland

Founded

2000

Website

http://syngentaventures.com

LinkedIn

https://linkedin.com/company/syngentagroup/about

Twitter

https://twitter.com/syngentagroup

What they look for

strategically relevant to agriculture innovation supporting Syngenta's core businesses (crop protection, seeds); technologies/business models with potential to transform agriculture/sustainability; global geography with emerging markets emphasis (e.g., India, Brazil); preference for platform/product/business model innovation; strong IP/teams without red flags like unproven tech or unrealistic projections

Preparing to pitch Syngenta Group Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.